STENTYS S.A. (ENXTPA:STNT) entered into an exclusive negotiations agreement to acquire Minvasys for €7.4 million on January 30, 2018. STENTYS S.A. signed a definitive agreement to acquire Minvasys for €7.5 million on February 15, 2018. The consideration will be paid approximately €6.5 million in cash as well as issue of 0.6 million shares of STENTYS. The transaction will be financed through a €7 million to €9 million capital increase through rights issue. Bpifrance would participate in the rights issue. As of February 21, 2018, STENTYS S.A. launched a €11.8 million rights issue to finance the acquisition of MINVASYS. MINVASYS' Directors are not planned to be appointed to the STENTYS Board of Directors. The transaction would be subject to compliance with the usual legal and regulatory provisions including the implementation, within Minvasys, of the procedure foreseen by the French Commercial Code and to the signing of the definitive agreements by MINVASYS' shareholders and financing conditions. Thibault Chareton and Charlotte Striffler of Harlay Avocats acted as legal advisors for the sellers of Minvasys. Morgan Hunault-Berret, Paul-Albert Legrand and Alice Laroque of Villechenon acted as legal advisors for Stentys.